Glamorous AI selected for International Trade’s Digital Health Campaign – ‘The First 100 Playbook’

Glamorous AI has been chosen to be a part of the DIT ‘First 100’; a list of innovative and emerging UK digital health-tech companies. The Department for International Trade’s UK Digital Health Playbook, ‘The First 100 Companies’, showcases the “best of British talent in Digital Health that’s ready to go global”. Noor Shaker, CEO of […]

Read more
Our CEO is live today giving a keynote at Pharma R&D summit

Our CEO, Noor Shaker, is giving a keynote at Pharma R&D Informatics, Medicinal Chemistry and Cannabinoids Summit. The talk will cover challenges and opportunities for AI in drug discovery and how our platform Rosalind addresses existing challenges open new possibilities for the discovery of novel chemistry.

Read more
Our CEO to join Novartis UK CSO in a panel discussion about diversity

On the 11th of November, the PM Society is organising a panel discussion around diversity and inclusion in Pharma and biotech. The panel is chaired by Hassan Chaudhury, the chair of PM Society diversity group and will feature Dr Samin Saeed, Chief Scientific Officer at Novartis UK and our CEO, Noor Shaker. Registration is free and […]

Read more
Glamorous AI participates in BioEurope Digital

Over the last week of October, we participated in BioEurope 2020. Although the event went digital this year, we really enjoyed a productive week of meetings with partners and collaborators. We are excited to see such interest in our approach and looking forward to progress our discussions and support drug discovery programs with our unique […]

Read more